Notably, NAbs and Ad5 antibodies were also elevated at Month 6 in the Placebo group (Fig 2C and 2D and S1 Table), which could again be attributed to asymptomatic infections or if participants did not report receiving the publically available vaccine that was available in December 2020 [17,18]. This evidence concerns the gene PSEN2 and infection.